December 13, 2019   ISSUE ALERT Volume 44, Issue 20 Check out the digital edition!   Study: Therapy reduces proptosis, diplopia in TED Teprotumumab was shown in a study to markedly reduce proptosis and diplopia in patients with thyroid eye disease. Find out more ADVERTISEMENT   Traversing the CXL pathway: Where do we go from here? New understanding of the effect of oxygen on crosslinking may allow clinicians to compensate for the lack of oxygen. Learn more   Small changes can help beat endophthalmitis bug Endophthalmitis rates after intravitreal injections can decrease with the implementation of a few relatively easy changes. Learn more   JOB OPPORTUNITIES   VT - University of Vermont